CIDETEC faces the new era of Nanomedicine

During two days the audience has assisted to 25 talks covering aspects on how to be prepared for translational research in early stage of development, new technologies for manufacturing, advanced characterization and regulation.

We had the opportunity to learn about regulatory aspects with César Hernandez (head of the department of medicines for Human Use). Pilar Calvo from Pharmamar, and Gemma Lahuerta from Reig Jofre showed us the pharma industry perspectives and key aspects for translation. Patrick Boisseau presented the initiatives from the European Nanomedicine Platform to promote the translation of nanomedicine and we also learnt from first level researchers as Abhay Pandit from the National University of Ireland in Galway and Simó Schwartz from Vall d’Hebron Institute of Research.

The assistants had the opportunity to participate in a demonstration in microfluidics and visit the new pilot plant built in CIDETEC for the manufacturing of investigational medicinal products.

25 November, 2016 · Overview

Congratulations to our partner Maria José Alonso

The National Academy of Medicine announced today the election of 70 regular members and 9 international members during its annual meeting. Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.
Newly elected international members are:

Maria Jose Alonso, Pharm.D, Ph.D., full professor, faculty of pharmacy, University of Santiago de Compostela, Santiago, Spain Read more

25 November, 2016 · Overview

Interview to two partners of the NanoPilot consortium-Cincodias newsletter

El que será el primer laboratorio español con capacidad para producir nanofármacos ya se está construyendo en San Sebastián. Las obras concluirán en febrero y, si todo va sobre lo previsto, conseguirá acreditarse para empezar a funcionar a mediados de año. Llama la atención que un país pionero en nanomedicina nunca haya sido capaz de acabar el proceso entero. Hasta ahora, las ayudas a la investigación en esta materia estaban muy enfocadas al desarrollo de la I+D. Faltaba el último empujón para no tener que llevarse la producción al extranjero. Read more